Avior Wealth Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RRAM
RA
Avior Wealth Management's HAE Position: Q1 2025 in Review
Avior Wealth Management sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 170 shares — an estimated $13.3K sold.
Avior Wealth Management first reported a position in HAE in Q4 2017 and held it in 19 quarters. The position peaked at $404K in Q3 2021. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.
- Avior Wealth Management reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
- Avior Wealth Management sold 170 Haemonetics shares in Q1 2025, an estimated $13.3K.
- Avior Wealth Management first reported a position in Haemonetics in Q4 2017 and held it in 19 quarters.
- Avior Wealth Management's Haemonetics position peaked at $404K in Q3 2021.
- 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.
Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.